Regulation of serotonin 1b receptor by glycogen synthase kinase-3

Molecular Pharmacology

Volumn 76, Issue 6, 2009, Pages 1150-1161

  Chen, Ligong ^a   Salinas, Gregory D ^a   Li, Xiaohua ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYCLIC AMP; FORSKOLIN; GLYCOGEN SYNTHASE KINASE 3; SEROTONIN 1B RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BENZAMIDES; BENZAZEPINES; CELL LINE; CHO CELLS; CHOLERA TOXIN; CRICETINAE; CRICETULUS; CYCLIC AMP; FORSKOLIN; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INDOLES; MALE; MALEIMIDES; MICE; MICE, INBRED BALB C; OXADIAZOLES; OXIMES; PIPERIDINES; PIPERIDONES; PROTEIN KINASE INHIBITORS; PURINES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN; SPIRO COMPOUNDS;

EID: 73149113991     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.056994     Document Type: Article

References (40)

1. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, and Bouvier M (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A 97:3684-3689.
2. 1B receptor knockout mice. J Neurochem 75:2415-2426.
3. Beaulieu JM (2007) Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. Int J Neuropsychopharmacol 10:3-6.
4. Bruinvels AT, Landwehrmeyer B, Gustafson EL, Durkin MM, Mengod G, Branchek TA, Hoyer D, and Palacios JM (1994) Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33:367-386.
5. Chalecka-Franaszek E and Chuang DM (1999) Lithium activates the serine/ threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci U S A 96:8745-8750.
6. Cross DA, Alessi DR, Cohen P, Andjelkovich M, and Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
7. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, and Cohen P (1994) The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogenactivated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303:21-26.
8. De Sarno P, Li X, and Jope RS (2002) Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43:1158-1164.
9. Doble BW and Woodgett JR (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175-1186.
10. Eldar-Finkelman H, Argast GM, Foord O, Fischer EH, and Krebs EG (1996) Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. Proc Natl Acad Sci U S A 93:10228-10233.
11. Embi N, Rylatt DB, and Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107:519-527.
12. Fiol CJ, Mahrenholz AM, Wang Y, Roeske RW, and Roach PJ (1987) Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J Biol Chem 262:14042-14048.
13. Frame S, Cohen P, and Biondi RM (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7:1321-1327.
14. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, and Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107-144.
15. Gingrich JA and Hen R (2001) Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 155: 1-10.
16. Goode N, Hughes K, Woodgett JR, and Parker PJ (1992) Differential regulation of glycogen synthase kinase-3β by protein kinase C isotypes. J Biol Chem 267: 16878-16882.
17. Gray JA, Compton-Toth BA, and Roth BL (2003) Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization. Biochemistry 42: 10853-10862.
18. Hannon J and Hoyer D (2008) Molecular biology of 5-HT receptors. Behav Brain Res 195:198-213.
19. Hsu EH, Lochan AC, and Cowen DS (2001) Activation of Akt1 by human 5-hydroxytryptamine (serotonin)1B receptors is sensitive to inhibitors of MEK. J Pharmacol Exp Ther 298:825-832.
20. Januel D, Massot O, Poirier MF, Olié JP, and Fillion G (2002) Interaction of lithium with 5-HT(1B) receptors in depressed unipolar patients treated with clomipramine and lithium versus clomipramine and placebo: preliminary results. Psychiatry Res 111:117-124.
21. Jope RS and Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95-102.
22. Jope RS and Roh MS (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7:1421-1434.
23. Klein PS and Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 93:8455-8459.
24. Liang MH and Chuang DM (2006) Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. J Biol Chem 281:30479-30484.
25. Marion S, Oakley RH, Kim KM, Caron MG, and Barak LS (2006) A β-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. J Biol Chem 281:2932-2938.
26. Massot O, Rousselle JC, Fillion MP, Januel D, Plantefol M, and Fillion G (1999) 5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders. Neuropsychopharmacology 21:530-541.
27. Meijer L, Flajolet M, and Greengard P (2004) Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 25:471-480.
28. Moro O, Lameh J, Högger P, and Sadée W (1993) Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. J Biol Chem 268:22273-22276.
29. Premont RT (2005) Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity. Neuromolecular Med 7:129-147.
30. Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, and Garnovskaya MN (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92:179-212.
31. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, and Polakis P (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023-1026.
32. Seamon KB, Padgett W, and Daly JW (1981) Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci U S A 78:3363-3367.
33. Stenfors C, Werner T, and Ross SB (1998) In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299. Naunyn Schmiedebergs Arch Pharmacol 357:500-507.
34. Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, and Greengard P (2006) Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311:77-80.
35. Takashima A (2006) GSK-3 is essential in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 9 (3 Suppl):309-317.
36. Turner JH, Gelasco AK, and Raymond JR (2004) Calmodulin interacts with the third intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct sites: putative role in receptor phosphorylation by protein kinase C. J Biol Chem 279:17027-17037.
37. Wang QM, Park IK, Fiol CJ, Roach PJ, and DePaoli-Roach AA (1994) Isoform differences in substrate recognition by glycogen synthase kinases 3 alpha and 3 beta in the phosphorylation of phosphatase inhibitor 2. Biochemistry 33:143-147.
38. Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/ factor A. EMBO J 9:2431-2438.
39. Woodgett JR (2003) Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders. Curr Drug Targets Immune Endocr Metabol Disord 3:281-290.
40. Zhang F, Phiel CJ, Spece L, Gurvich N, and Klein PS (2003) Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J Biol Chem 278:33067-33077.